<DOC>
	<DOCNO>NCT02955641</DOCNO>
	<brief_summary>The purpose study evaluate efficacy need prescribe anti-inflammatory topical drop patient undergo laser peripheral iridotomy .</brief_summary>
	<brief_title>Efficacy Necessity Anti-inflammatory Drops After Laser Peripheral Iridotomy</brief_title>
	<detailed_description>Primary close angle glaucoma responsible almost half glaucoma related blindness around world . Laser peripheral iridotomy ( LPI ) common simple treatment use treatment prevention acute angle closure event . Anti-inflammatory drop commonly prescribe patient undergo LPI order prevent reduce post-treatment discomfort . However , date , specific guideline post LPI anti-inflammatory treatment , sufficient clinical evidence regard efficacy treatment . In current study , investigator aim evaluate effect topical steroid non-steroidal anti-inflammatory drug ( NSAIDs ) post LPI symptom inflammation marker .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Angle-Closure</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis primary narrow/closed angle gonioscopy Able give consent Ability attend followup visit Corneal disease prevent sufficient evaluation angle Secondary close angle ( e.g . uveitis relate ) Pregnant woman Previous eye surgery laser refractive correction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Laser peripheral iridotomy</keyword>
	<keyword>topical anti-inflammatory drop</keyword>
</DOC>